Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Outcomes of Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Adrenal Metastases from a Single Institution.
Hoegen-Saßmannshausen P, Jessen I, Buchele C, Schlüter F, Rippke C, Renkamp CK, Weykamp F, Regnery S, Liermann J, Meixner E, Hoeltgen L, Eichkorn T, König L, Debus J, Klüter S, Hörner-Rieber J. Hoegen-Saßmannshausen P, et al. Among authors: rippke c. Cancers (Basel). 2024 Jun 19;16(12):2273. doi: 10.3390/cancers16122273. Cancers (Basel). 2024. PMID: 38927978 Free PMC article.
Impact of daily plan adaptation on accumulated doses in ultra-hypofractionated magnetic resonance-guided radiation therapy of prostate cancer.
Xiong Y, Rabe M, Rippke C, Kawula M, Nierer L, Klüter S, Belka C, Niyazi M, Hörner-Rieber J, Corradini S, Landry G, Kurz C. Xiong Y, et al. Among authors: rippke c. Phys Imaging Radiat Oncol. 2024 Feb 25;29:100562. doi: 10.1016/j.phro.2024.100562. eCollection 2024 Jan. Phys Imaging Radiat Oncol. 2024. PMID: 38463219 Free PMC article.
Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer.
Fink CA, Buchele C, Baumann L, Liermann J, Hoegen P, Ristau J, Regnery S, Sandrini E, König L, Rippke C, Bonekamp D, Schlemmer HP, Debus J, Koerber SA, Klüter S, Hörner-Rieber J. Fink CA, et al. Among authors: rippke c. Front Oncol. 2024 Feb 15;14:1308406. doi: 10.3389/fonc.2024.1308406. eCollection 2024. Front Oncol. 2024. PMID: 38425342 Free PMC article.
Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases.
Weykamp F, Hoegen P, Regnery S, Katsigiannopulos E, Renkamp CK, Lang K, König L, Sandrini E, Meixner E, Rippke C, Buchele C, Liermann J, Debus J, Klüter S, Hörner-Rieber J. Weykamp F, et al. Among authors: rippke c. Cancers (Basel). 2023 May 17;15(10):2786. doi: 10.3390/cancers15102786. Cancers (Basel). 2023. PMID: 37345123 Free PMC article.
Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy.
Regnery S, Leiner L, Buchele C, Hoegen P, Sandrini E, Held T, Deng M, Eichkorn T, Rippke C, Renkamp CK, König L, Lang K, Adeberg S, Debus J, Klüter S, Hörner-Rieber J. Regnery S, et al. Among authors: rippke c. Radiat Oncol. 2023 May 29;18(1):92. doi: 10.1186/s13014-023-02284-7. Radiat Oncol. 2023. PMID: 37248504 Free PMC article.
To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomes.
Regnery S, Katsigiannopulos E, Hoegen P, Weykamp F, Sandrini E, Held T, Deng M, Eichkorn T, Buchele C, Rippke C, Renkamp CK, König L, Lang K, Thomas M, Winter H, Adeberg S, Klüter S, Debus J, Hörner-Rieber J. Regnery S, et al. Among authors: rippke c. Lung Cancer. 2023 May;179:107175. doi: 10.1016/j.lungcan.2023.03.011. Epub 2023 Mar 21. Lung Cancer. 2023. PMID: 36965207
23 results